Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 6.99% is 14% below its 5-year average of 8.14%, around the middle of its 5-year range (-5.51%–14.46%).
0.97% above its 12-month average of 6.92%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 8.01%.
NET PROFIT MARGIN
6.99%
NET PROFIT MARGIN AVG TTM
6.92%
NET PROFIT MARGIN AVG 3Y
6.35%
NET PROFIT MARGIN AVG 5Y
8.14%
NET PROFIT MARGIN AVG 10Y
8.52%
NET PROFIT MARGIN AVG 15Y
8.28%
NET PROFIT MARGIN AVG 20Y
9.20%
CURRENT VS TTM AVG
+0.97%
CURRENT VS 3Y AVG
+10.06%
CURRENT VS 5Y AVG
-14.09%
CURRENT VS 10Y AVG
-17.92%
CURRENT VS 15Y AVG
-15.57%
CURRENT VS 20Y AVG
-24.05%
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-24.06%
vs the sector median at left
Labcorp Holdings Inc.
Market Cap
$25.55B
Net Profit Margin
6.99%
TTM Avg
6.92%
3Y Avg
6.35%
5Y Avg
8.14%
Market Cap
$25.94B
Net Profit Margin
9.19%
TTM Avg
8.91%
3Y Avg
9.15%
5Y Avg
11.71%
Market Cap
$26.14B
Net Profit Margin
21.91%
TTM Avg
21.94%
3Y Avg
21.74%
5Y Avg
21.20%
Market Cap
$24.62B
Net Profit Margin
27.71%
TTM Avg
12.90%
3Y Avg
13.00%
5Y Avg
12.11%
Market Cap
$24.37B
Net Profit Margin
16.98%
TTM Avg
16.55%
3Y Avg
18.38%
5Y Avg
18.84%
Market Cap
$28.88B
Net Profit Margin
7.86%
TTM Avg
10.12%
3Y Avg
9.68%
5Y Avg
22.03%
Market Cap
$21.10B
Net Profit Margin
41.56%
TTM Avg
41.73%
3Y Avg
40.84%
5Y Avg
37.71%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $25.55B | 6.99% | 6.92% | 6.35% | 8.14% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.94B | 9.19% | 8.91% | 9.15% | 11.71% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.14B | 21.91% | 21.94% | 21.74% | 21.20% |
| Incyte Corporation (INCY)vs › | $24.62B | 27.71% | 12.90% | 13.00% | 12.11% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.37B | 16.98% | 16.55% | 18.38% | 18.84% |
| BioNTech SE (BNTX)vs › | $24.30B | -62.98% | -31.89% | 3.77% | 12.08% |
| Medline Inc. (MDLN)vs › | $27.51B | 2.31% | 4.39% | 2.42% | 2.42% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $28.88B | 7.86% | 10.12% | 9.68% | 22.03% |
| United Therapeutics Corporation (UTHR)vs › | $21.10B | 41.56% | 41.73% | 40.84% | 37.71% |
| Waters Corporation (WAT)vs › | $30.54B | 3.58% | 20.93% | 21.85% | 22.39% |
Operating Margin
11.3%
Net Profit Margin
7.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 8.01% |
| 2026-03-31 | 7.85% |
| 2025-12-31 | 4.68% |
| 2025-09-30 | 7.33% |
| 2025-06-30 | 6.74% |
| 2025-03-31 | 6.36% |
| 2024-12-31 | 4.31% |
| 2024-09-30 | 5.16% |
| 2024-06-30 | 6.37% |
| 2024-03-31 | 7.18% |
| 2023-12-31 | -5.51% |
| 2023-09-30 | 6.00% |
| 2023-06-30 | 6.23% |
| 2023-03-31 | 7.01% |
| 2022-12-31 | 2.07% |
| 2022-09-30 | 12.31% |
| 2022-06-30 | 12.27% |
| 2022-03-31 | 12.61% |
| 2021-12-31 | 13.63% |
| 2021-09-30 | 14.46% |
| 2021-06-30 | 12.17% |
| 2021-03-31 | 18.49% |
| 2020-12-31 | 20.90% |
| 2020-09-30 | 18.05% |
| 2020-06-30 | 8.36% |
| 2020-03-31 | -11.23% |
| 2019-12-31 | 7.69% |
| 2019-09-30 | 7.54% |
| 2019-06-30 | 6.61% |
| 2019-03-31 | 6.65% |
| 2018-12-31 | 5.66% |
| 2018-09-30 | 13.80% |
| 2018-06-30 | 8.16% |
| 2018-03-31 | 6.08% |
| 2017-12-31 | 25.28% |
| 2017-09-30 | 6.80% |
| 2017-06-30 | 7.42% |
| 2017-03-31 | 7.85% |
| 2016-12-31 | 7.59% |
| 2016-09-30 | 7.43% |
| 2016-06-30 | 8.15% |
| 2016-03-31 | 6.77% |
| 2015-12-31 | 4.96% |
| 2015-09-30 | 6.59% |
| 2015-06-30 | 7.42% |
| 2015-03-31 | 0.04% |
| 2014-12-31 | 7.91% |
| 2014-09-30 | 8.84% |
| 2014-06-30 | 9.32% |
| 2014-03-31 | 7.91% |
| 2013-12-31 | 8.79% |
| 2013-09-30 | 10.14% |
| 2013-06-30 | 10.35% |
| 2013-03-31 | 10.22% |
| 2012-12-31 | 8.55% |
| 2012-09-30 | 10.43% |
| 2012-06-30 | 10.77% |
| 2012-03-31 | 11.35% |
| 2011-12-31 | 9.91% |
| 2011-09-30 | 9.56% |
| 2011-06-30 | 8.76% |
| 2011-03-31 | 9.29% |
| 2010-12-31 | 10.17% |
| 2010-09-30 | 10.97% |
| 2010-06-30 | 12.41% |
| 2010-03-31 | 11.12% |
| 2009-12-31 | 12.25% |
| 2009-09-30 | 11.09% |
| 2009-06-30 | 11.73% |
| 2009-03-31 | 11.49% |
| 2008-12-31 | 10.55% |
| 2008-09-30 | 9.86% |
| 2008-06-30 | 9.08% |
| 2008-03-31 | 11.81% |
| 2007-12-31 | 11.37% |
| 2007-09-30 | 10.90% |
| 2007-08-01 | 12.34% |
| 2007-03-31 | 12.27% |
| 2006-12-31 | 11.54% |
| 2006-09-30 | 12.05% |
| 2006-06-30 | 12.88% |
| 2006-03-31 | 11.60% |
| 2005-12-31 | 10.81% |
| 2005-09-30 | 11.10% |
| 2005-06-30 | 12.42% |
| 2005-03-31 | 12.09% |
| 2004-12-31 | 11.06% |
| 2004-09-30 | 11.85% |
| 2004-06-30 | 12.53% |
| 2004-03-31 | 11.60% |
| 2003-12-31 | 10.61% |
| 2003-09-30 | 11.05% |
| 2003-06-30 | 11.62% |
| 2003-03-31 | 10.38% |
| 2002-12-31 | 8.15% |
| 2002-09-30 | 8.75% |
